Content about Andrology

March 10, 2014

Ansell, the makers of LifeStyles Condoms, announced the launch of Epic, a new sexual enhancement product for males.

ISELIN, N.J. — Ansell, the makers of LifeStyles Condoms, announced the launch of Epic, a new sexual enhancement product for males.

Epic is a quick-drying topical spray that delays ejaculation by reducing the sensitivity of the penis. The spray features DermaSys technology, a patented transdermal delivery system which optimizes topical delivery through a highly effective absorption process. It also contains Lidocaine, a mild anesthetic that begins working almost immediately after application.

May 31, 2013

Sam's Club will host free health screenings for men's health next month, the club retailer said.

BENTONVILLE, Ark. — Sam's Club will host free health screenings for men's health next month, the club retailer said.

Sam's Club said it would offer free screenings at all of its 565 stores with pharmacies on June 8 for Men's Health Month. The screenings include screenings for prostate cancer, as well as thyroid tests for women, blood pressure tests, body mass index and vision tests.

April 1, 2013

E.p.t, creator of the original home pregnancy test, has partnered with the American Fertility Association to support the vast community of those who are actively trying to conceive during National Infertility Awareness Month this April.

TREVOSE, Pa. — E.p.t, creator of the original home pregnancy test, has partnered with the American Fertility Association to support the vast community of those who are actively trying to conceive, or TTC, during National Infertility Awareness Month this April.

March 15, 2013

The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.

CHICAGO — The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.

AbbVie announced the approval of the new version of AndroGel (testosterone) 1.62%, available in a packet containing 40.5 mg of testosterone in 2.5 g of gel and a packet with 20.25 mg of testosterone in 1.25 g of gel. The drug is used to raise testosterone levels in men with low or no testosterone, known as hypogonadism, estimated to affect nearly 14 million men in the United States.

February 1, 2013

Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

OAKLAND, Calif. — Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

The study, which the healthcare system called the first to show a significant difference in risk between short-acting and long-acting opioids, appeared in The Clinical Journal of Pain.

November 7, 2012

Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation.

NEWPORT BEACH, Calif. — Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation. The product is presently available at www.Promescent.com, through doctors’ offices and independent pharmacies. 

 Created by a urologist, the spray is designed to absorb below the surface of the skin where nerve endings that control ejaculation are located.

October 4, 2012

Membership-based retailer Sam's Club is offering free health screenings for women, the company said.

BENTONVILLE, Ark. — Membership-based retailer Sam's Club is offering free health screenings for women, the company said.

September 12, 2012

Abbott on Wednesday launched Drive for Five, a multifaceted, disease education and men's health awareness initiative, to encourage men to take a more proactive approach to their personal health.

NEW YORK — Abbott on Wednesday launched Drive for Five, a multifaceted, disease education and men's health awareness initiative, to encourage men to take a more proactive approach to their personal health.

September 4, 2012

The Food and Drug Administration has approved a new drug made by Astellas Pharma U.S. and Medivation for treating prostate cancer, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Astellas Pharma U.S. and Medivation for treating prostate cancer, the agency said Friday.

The FDA announced the approval of Xtandi (enzalutamide) for castration-resistant prostate cancer that has spread or recurred despite medical or surgical therapy to minimize testosterone.

August 15, 2012

The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

Wockhardt, based in Mumbai, India, announced the approval of alfuzosin hydrochloride extended-release tablets in the 10-mg strength, which is designed to treat enlarged prostate, also known as benign prostatic hyperplasia.

The drug is a generic version of Sanofi's Uroxatral. Various versions of the drug have sales of about $81.5 million, according to IMS Health.

May 31, 2012

Sam's Club is marking Men's Health Month in June by offering free men's health screenings at its pharmacies.

BENTONVILLE, Ark. — Sam's Club is marking Men's Health Month in June by offering free men's health screenings at its pharmacies.

April 13, 2012

A lot of retailers offer screenings for everything from diabetes to allergies, but what sets Sam’s Club apart is the scale on which it delivers them.

A lot of retailers offer screenings for everything from diabetes to allergies, but what sets Sam’s Club apart is the scale on which it delivers them. The club retailer offers screenings for everything from heart health and women’s health to diabetes. In a recent interview with Drug Store News, director of business development for health and wellness Angie Muldoon said that the company had conducted more than 1 million screenings in 2011.


February 8, 2012

A new at-home test that analyzes a male's sperm count has entered the market.

CHARLOTTESVILLE, Va. — A new at-home test that analyzes a male's sperm count has entered the market.

September 13, 2011

Impax Labs has hit a roadblock in its attempt to market a generic version of a symptomatic benign prostatic hyperplasia drug.

HAYWARD, Calif. — Impax Labs has hit a roadblock in its attempt to market a generic version of a symptomatic benign prostatic hyperplasia drug.

June 13, 2011

A new survey indicated that almost 70% of men have an easier time taking care of their cars than their own health.

NEW YORK — A new survey indicated that almost 70% of men have an easier time taking care of their cars than their own health.

The survey of 501 men ages 45 to 65 years, which was commissioned by the Men’s Health Network and drug maker Abbott, also found that more than 40% would be more likely to address car issues than health issues, while 28% don’t visit the doctor regularly, and 56% said they were more worried about their spouse’s health than their own.

May 18, 2011

A branded drug made by Watson Pharmaceuticals reduced symptoms in men with prostate disease, according to results of a mid-stage clinical trial.

WASHINGTON — A branded drug made by Watson Pharmaceuticals reduced symptoms in men with prostate disease, according to results of a mid-stage clinical trial.

Data from the phase-2 study of the drug Rapaflo (silodosin) presented at the American Urological Association’s annual meeting showed that it reduced symptoms and improved outcomes in men with chronic prostatitis/pelvic pain syndrome, also known as CP/CPPS.

March 3, 2011

Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

PASADENA, Calif. — Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

The study, sponsored by Kaiser Permanente and published online in the Journal of Urology, found that men who took nonsteroidal anti-inflammatory drugs, or NSAIDs, three times a day for more than three months were 2.4 times as likely to have erectile dysfunction as men who didn’t take the drugs regularly. The study used data from 80,966 men ages 45 to 69 years in California.

March 1, 2010

The Food and Drug Administration has approved the first generic version of a drug for...

February 25, 2010

Male fertility tests measuring sperm counts may soon be sold at retail, according to a...